Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
Status unconfirmed
Conditions studied: Hyperuricemia
In brief
An observational study to evaluate the prevalence of US changes of gout in the joints and tendons of patients with different degrees of asymptomatic hyperuricemia. The investigators' findings may support the extension of the spectrum of urate disease, and define a subset of patients that may benefit from early urate-lowering therapy.
Key facts
- Study ID
- NCT02502565
- Run by
- Washington D.C. Veterans Affairs Medical Center
- People needed
- 150
- Starts
- 2012-01-01
- Expected to finish
- 2019-03-01
- Last updated by the study team
- 2018-06-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients must have at least one serum uric acid level l ≥ 7.0 mg/dL within the last two years without a clinical diagnosis of gout per American College of Rheumatology criteria30 (appendix A).
- Patients, of matched gender and age, with normal uric acid levels will serve as controls.
You may not qualify if…
- Patients who meet or have met the ACR criteria for Gout, unable to read English, and/or have terminal illness will not be eligible to participate in the study.
- Patients with a diagnosis of skin psoriasis31, rheumatoid arthritis, or spondyloarthropathies will not be eligible to participate.
- Patients who are on urate-lowering therapy.
- Patients with 1 or 2 total knee replacements.
Where it is running
- Howard University Hospital — Washington D.C., District of Columbia, United States
- WashingtonVAMC — Washington D.C., District of Columbia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.